quantitative presentation
TRANSCRIPT
-
7/28/2019 Quantitative Presentation
1/39
Critical appraisalof quantitative
researchNovember 2010
Sarah Lawson
Research & Learning Support
1
mailto:[email protected]:[email protected] -
7/28/2019 Quantitative Presentation
2/39
Learningobjectives Understandtheprinciplesofcriticalappraisalanditsrole
inevidencebasedpractice
Understandthedifferentlevelsofquantitativeevidence
Be
able
to
appraise
quantitative
research
and
judge
its
validity
Beabletoassesstherelevanceofquantitativeresearchtotheirownwork
Knowaboutresourcesavailabletohelpthemtocriticallyappraiseresearch
Beabletocriticallyappraisequantitativeresearchasagroup
-
7/28/2019 Quantitative Presentation
3/39
Whatisevidencebasedpractice?
Evidencebasedpracticeistheintegrationof
individualclinical
expertise
withthe
best
available
external
clinical
evidence fromsystematicresearchand
patientsvalues
and
expectations
-
7/28/2019 Quantitative Presentation
4/39
Decisionorquestionarisingfroma
patientscare.
Formulateafocusedquestion.
Searchfor
the
best
evidence.
Appraisetheevidence.
Applythe
evidence.
Theevidencebasedpractice(EBP)
process.
-
7/28/2019 Quantitative Presentation
5/39
EBPinpractice
depending
upon
speciality,
between
50
and
80
per
centofall'medicalactivity'isevidencebased.
www.shef.ac.uk/scharr/ir.percent.html
http://www.shef.ac.uk/scharr/ir.percent.htmlhttp://www.shef.ac.uk/scharr/ir.percent.html -
7/28/2019 Quantitative Presentation
6/39
Whydoesevidencefromresearchfail
toget
into
practice?
75%cannotunderstandthestatistics
70%cannot
critically
appraise
aresearch
paper
Using
research
for
Practice:
a
UK
experience
of
the
barriers
scale.
Dunn,V.etal.
-
7/28/2019 Quantitative Presentation
7/39
Whatiscriticalappraisal?
Weighingupevidencetoseehowusefulitisindecisionmaking
Balancedassessmentofbenefitsandstrengthsofresearchagainstitsflawsand
weaknesses Assessresearchprocessandresults
Skillthatneedstobepracticedbyallhealthprofessionalsaspartoftheirwork
-
7/28/2019 Quantitative Presentation
8/39
WhatcriticalappraisalisNOT
Negativedismissal
of
any
piece
of
research
Assessmentofresultsalone
Basedentirely
on
statistical
analysis
Onlytobeundertakenbyresearchers/
statisticians
-
7/28/2019 Quantitative Presentation
9/39
Whydoweneedtocritically
appraise? Itusuallycomesasasurprisetostudentsto
learnthat
some
(the
purists
would
say
99%
of)
publishedarticlesbelonginthebinandshould
notbeusedtoinformpractice
Greenhalgh 2001
-
7/28/2019 Quantitative Presentation
10/39
Whydoweneedtocritically
appraise? studieswhichdon'treporttheirmethodsfully
overstatethebenefitsoftreatmentsbyaround25%
Khanetal.ArchInternmed,1996;Maheretal,Lancet1998.
studiesfunded
by
apharmaceutical
company
were
foundto be4timesaslikelytogiveresultsthatwerefavourabletothecompanythanindependentstudies
Lexchin etal,BMJ,2003
-
7/28/2019 Quantitative Presentation
11/39
Sourcesofbias
poorcontrolgroup/controldosage
surrogateoutcomes
ignoredropouts
modifytriallength
misusebaselinestatistics
statisticsoverload
-
7/28/2019 Quantitative Presentation
12/39
HowdoIappraise?
Mostlycommon
sense.
Youdonthavetobeastatisticalexpert!
Checklistshelp
you
focus
on
the
most
importantaspectsofthearticle.
Different
checklists
for
different
types
of
research.
Willhelpyoudecideifresearchisvalidand
relevant.
-
7/28/2019 Quantitative Presentation
13/39
Researchmethods
Quantitative
Usesnumbersto
describeand
analyse
Usefulforfindingpreciseanswersto
definedquestions
Qualitative
Useswordstodescribe
andanalyse
Usefulforfindingdetailedinformation
aboutpeoples
perceptionsand
attitudes
-
7/28/2019 Quantitative Presentation
14/39
Levelsofquantitativeevidence.
Systematicreviews.
Randomizedcontrolled
trials.
Prospectivestudies(cohortstudies).
Retrospective
studies
(case
control). Caseseriesandreports
Opinionsofrespectedauthorities.
-
7/28/2019 Quantitative Presentation
15/39
SystematicReviews.
Thoroughsearchofliteraturecarried
out. AllRCTs (orotherstudies)onasimilarsubjectsynthesisedandsummarised. Metaanalysistocombinestatistical
findingsofsimilarstudies.
-
7/28/2019 Quantitative Presentation
16/39
RandomisedControlledTrials
(RCTs)
Normaltreatment/placeboversusnewtreatment.
Participantsare
randomised.
Ifpossibleshouldbedoubleblinded.
Intentionto
treat
analysis
-
7/28/2019 Quantitative Presentation
17/39
Cohort studies prospective
groups (cohorts) exposure to a risk factor
followed over a period of time compare rates of development of anoutcome of interest
Confounding factors and bias
-
7/28/2019 Quantitative Presentation
18/39
Case control studies Retrospective
Subjects confirmed with a disease (cases)are compared with non-diseased subjects(controls) in relation to possible past
exposure to a risk factor.
Confounding factors and bias
-
7/28/2019 Quantitative Presentation
19/39
Appraising original researchAre
the
results
valid?
Istheresearchquestionfocused?
Wasthe
method
appropriate?
Howwasitconducted?
Whataretheresults?
Howwasdatacollectedandanalysed?
Aretheysignificant?
Willthe
results
help
my
work
with
patients?
-
7/28/2019 Quantitative Presentation
20/39
AppraisingRCTs
Recruitment and sample size Randomisation method and controls
Confounding factors Blinding
Follow-up Intention to treat analysis Censoring
-
7/28/2019 Quantitative Presentation
21/39
Appraisingsystematicreviews.
Wasathoroughliteraturesearchcarriedout?
Publicationbias
paperswithmoreinteresting resultsaremorelikelytobe: Submitted
for
publication Acceptedforpublication
Publishedinamajorjournal
Publishedin
the
English
language
-
7/28/2019 Quantitative Presentation
22/39
Publicationbias
AllSSRItrialsregisteredwithFDA
37studies
were
assessed
by
FDA
as
positive
36ofthesewerepublished. 22
studies
with
negative
or
inconclusive
resultswerenotpublishedand11were
writtenupaspositive.
Turneretal.NEJM,2008.
-
7/28/2019 Quantitative Presentation
23/39
Reviewsingeneralmedicaljournals
50reviewsin4majorjournals19856
Nostatementofmethods
Summaryinappropriate
Currentsystematic
reviews
do
not
routinely
usescientificmethodstoidentify,assessandsynthesiseinformation (Mulrow,1987)
-
7/28/2019 Quantitative Presentation
24/39
Istheresearchquestionfocused?
Patient (e.g.child) Intervention
(e.g.MMRvaccine)
Comparison (e.g.singlevaccines) Outcome (e.g.autism)
-
7/28/2019 Quantitative Presentation
25/39
Areresultssignificant?
Howwasdatacollected?
Whichstatistical
analyses
were
used?
Howprecisearetheresults?
Howare
the
results
presented?
-
7/28/2019 Quantitative Presentation
26/39
Intentiontotreatanalyses
Analysingpeople,attheendofthetrial,inthe
groupsto
which
they
were
randomised,
even
iftheydidnotreceivetheintended
intervention
-
7/28/2019 Quantitative Presentation
27/39
Statisticalanalyses
Oddsratios,absoluteandrelativerisks/benefits,hazardratios/relativehazards
Thelikelihoodofsomethinghappeningvs thelikelihoodofsomethingnothappeningNumber
needed
to
treat
(NNT)
Thenumberofpeopleyouwouldneedtotreattoseeoneadditionaloccurrenceofaspecific
beneficial
outcome
-
7/28/2019 Quantitative Presentation
28/39
OddsRatioDiagrams.(Blobbograms orForestPlots.)
-
7/28/2019 Quantitative Presentation
29/39
OddsRatioDiagrams
Lineof
no
effect
no
difference
between
treatmentandcontrolgroup
Result(blob)
to
the
Left
of
the
line
of
no
effect
=Lessoftheoutcomeinthetreatmentgroup.
ResulttotheRightoftheline=Moreoftheoutcome.
BUT Istheoutcomegoodorbad?
-
7/28/2019 Quantitative Presentation
30/39
Cardiacdeaths less=good
-
7/28/2019 Quantitative Presentation
31/39
Smokingcessation more=good
-
7/28/2019 Quantitative Presentation
32/39
ConfidenceIntervals.
Longerconfidenceinterval=less
confidentof
results
wider
range.
Shorterconfidenceinterval=more
confident narrower
range.
Crosseslineofnoeffect/nosignificance=
Inconclusiveresults.
-
7/28/2019 Quantitative Presentation
33/39
Confidenceintervals
-
7/28/2019 Quantitative Presentation
34/39
PValues.
Pstandsforprobability
howlikelyisthe
resultto
have
occurred
by
chance?
Pvalueoflessthan0.05meanslikelihoodofresultsbeingduetochanceislessthan1in20=statistically
significant.
Pvaluesandconfidenceintervalsshouldbe
consistent
-
7/28/2019 Quantitative Presentation
35/39
NumberNeededtoTreat
Thenumberofpeopleyouwouldneedto
treatto
see
one
additional
occurrence
of
aspecificbeneficialoutcome.
The
number
of
patients
that
need
to
be
treatedtopreventonebadoutcome.
-
7/28/2019 Quantitative Presentation
36/39
Areresultsrelevant?
CanIapplytheseresultstomyownpractice?
Ismylocalsettingsignificantlydifferent?
Arethesefindingsapplicabletomypatients?
Arefindingsspecific/detailedenoughtobe
applied? Werealloutcomesconsidered?
-
7/28/2019 Quantitative Presentation
37/39
Thegoodnews!
Someresourceshavealreadybeen
critically
appraised
for
you. Anincreasingnumberofguidelinesand
summaries
of
appraised
evidence
are
availableontheinternet.
-
7/28/2019 Quantitative Presentation
38/39
Summary.
Searchforresourcesthathavealreadybeen
appraisedfirst,
e.g.
Guidelines,
Cochrane
systematic
reviews.
Searchdownthroughlevelsofevidence,e.g.systematic
reviews,
RCTs.
Usecheckliststoappraiseresearch.
Howcan
these
results
be
put
into
practice?
-
7/28/2019 Quantitative Presentation
39/39
Questions?